Regulatory & Legal

Perrigo takes a massive $1.3B impairment charge and plans a 7% workforce reduction as it pivots to a 'CORE' business amid a challenging outlook.

Titan International beat expectations in Q4, driven by a 21% surge in its construction division, and now eyes a strong 2026 as OEM destocking ends.

A new platform is tackling the UK's fragmented services industry with rapid verification and fixed pricing, promising to end quote delays forever.

Techem's new sustainability report reveals an 11.2% CO2e drop, a major digital rollout with 85% smart devices, and new e-mobility and circular economy goals.

The environmental services giant surpassed 2025 targets, driven by its GreenUp strategy, major acquisitions in water tech, and a renewed global push.

The therapy giant reports robust revenue growth and record patient visits, backed by major acquisitions and new 10-year hospital system alliances.

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

The ad-tech giant posted record revenue for 2025, but a weaker-than-expected forecast for early 2026 sent its stock tumbling. What's next?

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

The Kentucky Derby operator posts record revenue and operational earnings, yet a 28% drop in quarterly net income reveals a complex story of growth and challenges.

With stellar clinical data and a full war chest, Terns is hitting the road to convince investors its leukemia drug, TERN-701, is a true disruptor.

Labour unions and students decry the Ford government's plan to shift OSAP from grants to loans, warning of crippling debt and reduced access to education.

Y Combinator-backed Coinrule now offers AI-driven trading for stocks and ETFs, entering a competitive market under the watchful eye of regulators.

With $125 million in hand, ClearThink 1 enters a recovering SPAC market, setting its sights on a transformative deal in the dynamic financial services sector.

A new bipartisan bill offers loan forgiveness to physical therapists who work in rural areas, aiming to fix critical healthcare shortages across America.

Timed with the World Cup, a new exhibition explores the untold stories of Chinese Canadian athletes who shaped Canada's identity and challenged its history.

New FieldReporter module replaces paper sign-ins with geolocated digital logs, promising real-time data integrity and proactive labor compliance.